The world of mental health is on the brink of a groundbreaking development. A recent, long-term scientific study has shown that microdosing with psilocybin - one of the active compounds in certain psychedelic mushrooms - may be more effective than traditional antidepressants for treating depression. This discovery not only represents a new, promising direction for the treatment of mental symptoms, but also helps break the old stigma surrounding psychedelics. In this blog post, we explain what this study means, why it is important and how it makes microdosing an increasingly common alternative.

The study, published on Medscape, was the first long-term study to compare the effect of microdosing with psilocybin to the effect of selective serotonin reuptake inhibitors (SSRIs), the most commonly prescribed group of antidepressants. The study involved hundreds of participants with moderate to severe depression, half of whom received psilocybin and the other half the antidepressant escitalopram (Lexapro).

After a six-month treatment period, it was found that the group using psilocybin achieved significantly better results than the group taking escitalopram. More participants in the psilocybin group experienced a significant reduction in their depressive symptoms and reported feeling 'more emotionally connected' and 'more alive' compared to the SSRI group. Although the SSRIs did provide relief from depressive symptoms, the effects were often described as emotional flatness, something that was much less common in the psilocybin group.

In addition, the psilocybin group reported fewer side effects. This is a crucial finding, as SSRIs are often associated with unpleasant side effects such as fatigue, libido loss and weight gain, which can reduce patients' quality of life.

Although the research focused on full therapeutic doses of psilocybin, the relevance to microdosing - using very small amounts of the substance - is great. The positive effects of psilocybin on brain chemistry are similar even with microdosing, and thus may contribute to improved mental health, mood and emotional well-being without the intensity of a full psychedelic experience.

What this research further confirms is that microdosing is no longer in the shadow of more conventional treatments. Psilocybin is being taken seriously as a potentially safer, more natural and effective alternative to synthetic antidepressants. With this shift toward normalizing microdosing, the old stigma surrounding psychedelics may slowly but surely be broken.

For a long time, psychedelics such as psilocybin were associated with the counterculture of the 1960s and there was much fear surrounding the use of these substances. Fortunately, solid scientific research, such as this new study, is bringing the truth to light. The stigma surrounding psychedelics is disappearing, and more and more people are seeing the potential of psilocybin, especially in microdosing, to help with mental health issues.

Microdosing offers users a subtle way to enjoy the benefits of psychedelics without the intense hallucinogenic effects associated with full doses. It helps improve mood, increase creativity and enhance an overall sense of well-being. As the use of psilocybin continues to gain scientific support, the social and legal landscape is also beginning to shift. The idea that psychedelics can be an effective, safe treatment method is becoming more normal.

The research on psilocybin has shown us that we may be at the forefront of a new approach to mental health care. Instead of numbing your mood, as antidepressants often do, psilocybin helps people feel more deeply connected to their emotions and environment. That's exactly what microdosing promises: more balance, without the drawbacks of traditional drugs.

At XtraPositive, we believe that microdosing with organic truffles should be accessible to everyone, as a natural and safe way to support mental health. More and more people are discovering the benefits of microdosing, and this study is helping to make it a common alternative in mental health care.

This scientific breakthrough is not only a victory for psilocybin, but also an important step in changing the way we view mental health. For those struggling with depression, anxiety or stress, microdosing offers a promising and natural alternative. The days when psychedelics were seen as taboo are behind us. Now is the time to embrace the power of microdosing and experience the benefits for yourself.

Curious to learn more details about the study and what it can do for you? Read the full study here.